Zobrazeno 1 - 10
of 97
pro vyhledávání: '"M. J. de Leon"'
Autor:
Ki-Wook Oh, Hee Jin Kim, Xiuyuan Wang, Ji-Yoon Park, Anup Deshpande, Maja Buj, Seung Hyun Kim, M. J. de Leon, Seong-il Oh
Publikováno v:
European Journal of Neurology. 24:122-129
Background and purpose Amyotrophic lateral sclerosis (ALS), a motor neuron disease, is associated with various cortical symptoms including mild cognitive decline with behavior changes, suggesting the involvement of extra-motor areas in ALS. Our aim w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a76dbd58e20cc2ada57633a8e76f0dd
https://doi.org/10.1111/ene.13163
https://doi.org/10.1111/ene.13163
Autor:
Nicole Spector, Alberto Pupi, Valentina Berti, M. J. de Leon, John D. Murray, Pauline McHugh, Michelle Davies, W. Tsui, Elizabeth Pirraglia, Schantel Williams, Lisa Mosconi, Yi Li, Shankar Vallabhajosula
Publikováno v:
The journal of nutrition, health & aging. 19:413-423
Epidemiological evidence linking diet, one of the most important modifiable lifestyle factors, and risk of Alzheimer's disease (AD) is rapidly increasing. However, there is little or no evidence for a direct association between dietary nutrients and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab716057f9ff4cf42e3696d4c2a57e05
https://doi.org/10.1007/s12603-014-0534-0
https://doi.org/10.1007/s12603-014-0534-0
Autor:
Pauline McHugh, Schantel Williams, Elizabeth Pirraglia, Michelle Davies, Ricardo S. Osorio, M. J. de Leon, W. Tsui, Lidia Glodzik, John D. Murray, Nicole Spector, Yi Li, Lisa Mosconi
Publikováno v:
The Journal Of Prevention of Alzheimer's Disease. :1-10
OBJECTIVES: Epidemiological evidence linking diet, one of the most important modifiable environmental factors, and risk of Alzheimer’s disease (AD) is rapidly increasing. Several studies have shown that higher adherence to a Mediterranean diet (MeD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46902484b35940274d36162ba5f5c9c2
https://doi.org/10.14283/jpad.2014.17
https://doi.org/10.14283/jpad.2014.17
Publikováno v:
Neurological Sciences. 32:559-569
Often viewed as a potential tool for preclinical diagnosis in early asymptomatic stages of Alzheimer’s disease (AD), the term “endophenotype” has acquired a recent popularity in the field. In this review, we analyze the construct of endophenoty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40651e06f8178ed76afc330701767abd
https://doi.org/10.1007/s10072-011-0633-1
https://doi.org/10.1007/s10072-011-0633-1
Autor:
J Giardin, David M. Rapoport, Indu Ayappa, Ram A. Sharma, J Rivas, Azizi Seixas, M J de Leon, Rebecca Robbins, A Godinho, Andrew W Varga, Ricardo S. Osorio, M D Miller
Publikováno v:
Sleep. 41:A108-A108
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfaaf7543334db2378f0f9d1c244b055
https://doi.org/10.1093/sleep/zsy061.280
https://doi.org/10.1093/sleep/zsy061.280
Autor:
Lidia Glodzik, Ricardo S. Osorio, Lisa Mosconi, Valentina Berti, M. J. de Leon, Yi Li, S. De Santi
Publikováno v:
PET Clinics. 5:15-31
Early diagnosis of Alzheimer disease (AD) is one of the major challenges for the prevention of this dementia. The pathologic lesions associated with AD develop many years before the clinical manifestations of the disease become evident, during a like
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15e0a204122100f7158d5a74bf9bf440
https://doi.org/10.1016/j.cpet.2009.12.003
https://doi.org/10.1016/j.cpet.2009.12.003
Publikováno v:
Neurodegenerative Diseases. 7:131-135
Preclinical diagnosis of Alzheimer’s disease (AD) is one of the major challenges for the prevention of AD. AD biomarkers are needed not only to reveal preclinical pathologic changes, but also to monitor progression and therapeutics. PET neuroimagin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5dee9101e26a55c37b7761a7a6de999
https://doi.org/10.1159/000289222
https://doi.org/10.1159/000289222
Autor:
Lisa Mosconi, Remigiusz Switalski, S. De Santi, Lidia Glodzik, L. A. Saint Louis, Kenneth Rich, Y. Yao, Domenico Praticò, M. J. de Leon, Wai Hon Tsui, Elizabeth Pirraglia, Miroslaw Brys, Jialin Li, Elizabeth Javier
Publikováno v:
Journal of Neurology. 254:1666-1675
Very little data exist to evaluate the value of longitudinal CSF biological markers for Alzheimer's disease (AD). Most studies indicate that tau and amyloid beta markers do not reflect disease progression. We now report on a longitudinal, three-time
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::771b9d4241d60553f80dd66e2233591f
https://doi.org/10.1007/s00415-007-0610-z
https://doi.org/10.1007/s00415-007-0610-z
Autor:
Ricardo S. Osorio, M. J. de Leon, Lidia Glodzik, Nobuyuki Okamura, S. De Santi, Henry Rusinek, Angela R. Kamer, Melanie B. Shulman, Tracy Butler, W. Tsui, Lisa Mosconi, Yi Li
Tomographic imaging is about 40 years old and has made considerable progress with the early and differential diagnosis of Alzheimer’s disease (AD). In this summary, we classified the imaging in AD into three major categories: (1) general descriptiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3f3e0d6d8dbb223b547270d6bcdac6b
https://doi.org/10.1016/b978-0-12-397025-1.00069-5
https://doi.org/10.1016/b978-0-12-397025-1.00069-5
Autor:
Tyler Gumb, Ricardo S. Osorio, Indu Ayappa, Lidia Glodzik, Janna Mantua, Elizabeth Pirraglia, Schantel Williams, Lisa Mosconi, M. J. de Leon
Publikováno v:
Neurodegenerative Diseases. 13:163-165
Background: The pathophysiological process of Alzheimer's disease (AD) begins many years before the emergence of clinical symptoms (preclinical AD). A hypothetical biomarker progression in the pathogenesis of AD has been suggested, beginning with the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2da3bd12cad073d4722d6f67e17d9beb
https://doi.org/10.1159/000355063
https://doi.org/10.1159/000355063